Skip to Main Content

The (POGO) Blog

June 13, 2018

By Bonnie Goldstein

Paper Cuts: Slow Stroll to Salad Safety



Collage of a person in a hospital gown, a person holding produce, and salmonella. A food safety regulation to prevent contamination of fresh fruits and vegetables still has not been implemented after seven years.

Continue Reading Paper Cuts: Slow Stroll to Salad Safety

Topics: Public Health and Science

June 7, 2018

By Rebecca Jones

Patient Advocates Get Big Funding from Big Pharma



Two people meet Senator Claire McCaskill (D-MO) introduced legislation compelling patient advocacy groups to report funding they receive from pharmaceutical companies. This added transparency will give the public a new lens through which to view actions of these groups.

Continue Reading Patient Advocates Get Big Funding from Big Pharma

Topics: Public Health and Science

December 14, 2017

By David S. Hilzenrath

Biotech Exec Hosted by Trump Butters Up FDA Chief



John F. Crowley The FDA fast tracked the experimental drug migalastat after Amicus Therapeutics CEO John F. Crowley sent a flattering personal note to FDA Commissioner Scott Gottlieb.

Continue Reading Biotech Exec Hosted by Trump Butters Up FDA Chief

Topics: Public Health and Science

October 10, 2017

By Christine Ostrosky

IG Calls for Detailed Reporting on Medical Device Failures



Emergency room A new report from a federal watchdog calls on the government to require hospitals to provide more detailed reporting on medical device problems to the Centers for Medicare and Medicaid Services (CMS). Better reporting could help the government identify mal

Continue Reading IG Calls for Detailed Reporting on Medical Device Failures

Topics: Public Health and Science

March 3, 2017

By David S. Hilzenrath

Trump’s Dangerous Prescription for the FDA



President Trump addressing a joint session of Congress, with VP Mike Pence and Rep. Paul Ryan seated behind him, clapping. President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.

Continue Reading Trump’s Dangerous Prescription for the FDA

Topics: Government Accountability, Open Government, Public Health and Science

Items 1 - 5 of 22  12345Next

Browse POGOBlog by Topic

POGO on Facebook